NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/20/2023
Back to search
Official data from USPTO
MAGXTRACT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
06/20/2023
Classification
Registered
Trademark type
Combined
Nice classes
10
Filing date
04/29/2021
Registration date
06/20/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/20/2023
Last transaction
06/20/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/15/2021
First use in commerce
09/03/2021
Drawing code
5
Owner type
03
Owner location
Taoyuan City, TW
Examiner
BEVERLY, JOSETTE
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording MAGXTRACT in a stylized font. The letter X in a bigger size.
Holders and representatives
Holders
Chroma ATE Inc.
Representatives
Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, P.C.
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Blood testing apparatus; medical instrument for monitoring blood properties and respiratory events; apparatus for use in medical analysismedical diagnostic instruments for the analysis of body fluids; testing apparatus for medical purposesimmunochemical testing apparatus for medical use; apparatus for DNA and RNA testing for medical purposes; blood analyzerblood oxygen monitors; immunoassay devices for medical useapparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; automated extraction instrumentssurgical instruments
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/20/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/17/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/16/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/26/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/26/2023
IUAF
USE AMENDMENT FILED
04/07/2023
EISU
TEAS STATEMENT OF USE RECEIVED
04/07/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/11/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/11/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/09/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/09/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/09/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/09/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/18/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/23/2022
PUBO
PUBLISHED FOR OPPOSITION
08/23/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/16/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/15/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/29/2021
GNSL
LETTER OF SUSPENSION E-MAILED
12/29/2021
CNSL
SUSPENSION LETTER WRITTEN
12/29/2021
DOCK
ASSIGNED TO EXAMINER
12/29/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/03/2021
NWAP
NEW APPLICATION ENTERED
05/03/2021
Continuous trademark protection
Get notified about every new filing that threatens MAGXTRACT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.